Dexcom Products: How It Works, Accuracy, and When to Use It

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Current Dexcom products include the G6 (legacy), G7 (flagship prescription CGM), Stelo (over-the-counter CGM), Follow app, and Clarity reporting platform.
  • The older G5 has been discontinued; the G6 is being phased out in favor of the smaller, more accurate G7.
  • Dexcom G7 is factory calibrated, lasts 10 days plus a 12-hour grace period, and has a published MARD of about 8.2% in adults.
  • Dexcom Stelo is an OTC CGM for adults not using insulin; it lasts 15 days per sensor and costs about $99 per month cash pay.
  • Dexcom Clarity produces reports clinicians use to adjust medication and lifestyle, including time in range and ambulatory glucose profile data.

Dexcom products include the G7 flagship CGM, the G6 (still sold during the G7 rollout), the over-the-counter Dexcom Stelo, plus the Dexcom Follow and Dexcom Clarity apps. All continuous glucose monitors use a small sensor under the skin to measure interstitial glucose every minute and display the data on a phone, watch, or dedicated receiver.

The Current Dexcom Product Lineup

Product Type Prescription? Wear Time MARD
Dexcom G7 CGM sensor + transmitter (all-in-one) Yes 10 days + 12-hour grace ~8.2%
Dexcom G6 CGM sensor + reusable transmitter Yes 10 days ~9%
Dexcom Stelo OTC CGM (all-in-one) No 15 days ~10%
Dexcom Follow Companion mobile app n/a n/a n/a
Dexcom Clarity Reporting platform n/a n/a n/a

Dexcom G5: Legacy Product, Discontinued

Dexcom G5 was the first CGM to broadcast directly to a smartphone without a separate receiver. It required two fingerstick calibrations per day and a reusable transmitter that clicked onto a new sensor every 7 days. Dexcom stopped shipping new G5 components when the G6 launched in 2018. Existing G5 users have been transitioned to the G6 or G7.

Dexcom G6: The Factory-Calibrated Workhorse

The Dexcom G6 introduced factory calibration, eliminating routine fingersticks. The sensor lasts 10 days and uses a separate transmitter that snaps onto each new sensor for a 3-month period. G6 is FDA-cleared for use in children as young as 2 and during pregnancy. It is compatible with insulin pump automated insulin delivery systems like Tandem t:slim X2 and Omnipod 5.

Many long-time users still prefer the G6 because the reusable transmitter format fits their routine. Dexcom has signaled that the G6 will gradually be phased out in favor of the G7.

Dexcom G7: The Flagship Prescription CGM

Dexcom G7, launched in the US in 2023, is the current flagship product. Key improvements over G6:

  • 60 percent smaller size with sensor and transmitter combined in one disposable patch.
  • 30-minute warm-up (down from 2 hours on G6).
  • 12-hour grace period after the 10-day sensor expires.
  • Improved accuracy, with published MARD around 8.2 percent.
  • Direct-to-Apple-Watch Bluetooth without phone relay.

G7 is approved for adults and children 2 and older, including during pregnancy. It supports automated insulin delivery systems from Tandem and Omnipod. For background on the CGM technology these products use, see the prediabetes 101 hub.

Dexcom Stelo: The Over-the-Counter Option

Dexcom Stelo is the first FDA-cleared over-the-counter CGM in the United States. Launched in 2024, it targets adults 18 and older who are not taking insulin, including people with type 2 diabetes on oral medication, prediabetes, or general metabolic curiosity. Key differences from G7:

Feature Dexcom G7 Dexcom Stelo
Prescription Yes No
Wear time 10 days + grace 15 days
Urgent low alert Yes No
Insulin pump integration Yes No
Approximate cash price Varies by insurance; ~$200-400/month without ~$99/month

Dexcom Follow: Sharing Data with Family

Dexcom Follow lets up to 10 designated “followers” see your real-time CGM data. Parents of children with type 1 diabetes, adult children of elderly parents with diabetes, and spouses commonly use it. Followers receive optional alerts for highs and lows on their own phones. The feature requires the wearer to actively invite each follower via email.

Dexcom Clarity: Reports for You and Your Clinician

Clarity converts raw CGM data into clinical reports including:

  • Ambulatory glucose profile (AGP), a 14-day standardized visualization.
  • Time in range (% between 70-180 mg/dL), time below range, time above range.
  • Estimated A1C, also called glucose management indicator (GMI).
  • Patterns by time of day.

Your clinician can use these reports to adjust medication doses, meal timing, and insulin ratios. According to the FDA, CGM-derived metrics like time in range are now part of mainstream diabetes care.

How to Apply a Dexcom Sensor

  1. Wash and dry the application area (upper arm for G7 and Stelo, abdomen also allowed for G6 and G7).
  2. Remove the applicator from the package, remove the safety cap.
  3. Press the applicator firmly against the skin and push the button.
  4. Pair with the app using NFC (tap the phone against the sensor).
  5. Wait 30 minutes for warm-up (G7 and Stelo) or 2 hours (G6).

Compatibility and Insulin Pumps

Dexcom G6 and G7 integrate with:

  • Tandem t:slim X2 insulin pump with Control-IQ algorithm.
  • Insulet Omnipod 5 tubeless pump.
  • iOS and Android smartphones; Apple Watch (G7 direct connection).

Dexcom Stelo does not integrate with pumps and is designed for information only.

Insurance and Cost

Dexcom G7 and G6 are covered by Medicare for people who use insulin or have a history of hypoglycemia. Most commercial plans cover Dexcom CGMs for type 1 and insulin-using type 2 diabetes; coverage for non-insulin type 2 varies. Dexcom Stelo is available directly through the Dexcom website and is typically paid out of pocket or through an HSA or FSA.

Who Is the Best Fit for Each Dexcom Product?

  • Type 1 diabetes or insulin-using type 2: Dexcom G7 with pump integration.
  • Non-insulin type 2 covered by insurance: Dexcom G7 as prescribed.
  • Prediabetes or non-insulin adult wanting OTC access: Dexcom Stelo.
  • Medicare recipient on intensive insulin: Dexcom G7 or G6 via covered DME supplier.
  • Existing G6 user happy with pumps: stay on G6 for now, plan to transition to G7.

For broader treatment context, see the treatment hub.

The Bottom Line

Dexcom products span from the legacy G6 to the flagship G7 to the over-the-counter Stelo, with Follow and Clarity apps providing data sharing and reporting. Picking the right one depends on whether you use insulin, what integrations matter, and whether insurance or cash pay fits your situation. Whichever product you choose, a CGM can give you pattern-level insight that fingersticks simply cannot provide.

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition or medication.

Frequently Asked Questions

What Dexcom products are currently available?

The active Dexcom lineup includes the Dexcom G7 (the flagship 10-day prescription CGM), the Dexcom G6 (still sold during the G7 transition), and Dexcom Stelo (an over-the-counter 15-day CGM for adults not using insulin). Companion software includes the Dexcom G7 app, Dexcom Follow app for loved ones, and Dexcom Clarity for clinician data review.

Is Dexcom G5 still sold?

No. Dexcom discontinued new G5 sensor shipments and transitioned users to G6 and G7. The G5 required 2 fingerstick calibrations per day and had a larger on-body footprint. The G6 introduced factory calibration and the 10-day sensor. The G7 went further by shrinking the size by 60 percent and improving accuracy.

What is the difference between Dexcom G7 and Dexcom Stelo?

Dexcom G7 is a prescription CGM approved for type 1, type 2, and gestational diabetes with alarms for highs and lows. Dexcom Stelo is an over-the-counter CGM for adults 18 and older who are not using insulin. Stelo lacks urgent-low alerts, does not integrate with insulin pumps, and lasts 15 days per sensor instead of 10.

What is Dexcom Clarity and Dexcom Follow?

Dexcom Clarity is a reporting platform where you or your clinician view trends, time in range, and an ambulatory glucose profile over 14 or 90 days. Dexcom Follow is a companion app that lets up to 10 caregivers or family members view your real-time CGM data with your permission. Both are free to download and require a paired Dexcom CGM.

Sources

  1. Dexcom Inc. Dexcom G7 User Guide. https://www.dexcom.com
  2. Dexcom Inc. Stelo by Dexcom User Guide. https://www.dexcom.com/stelo
  3. U.S. Food and Drug Administration. Continuous Glucose Monitoring. https://www.fda.gov/medical-devices/home-use-devices/continuous-glucose-monitoring
  4. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Technology. https://diabetesjournals.org/care